Benitec Biopharma Limited EV/EBIT

EV/EBIT of BNTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including EV/EBIT growth rates and interactive chart. EV/EBIT is a ratio that compares a company’s Enterprise Value (EV) to its Earnings Before Interest, Taxes (EBIT), but after Depreciation and Amortization.. The EV/EBIT ratio is a valuation metric used to compare the relative value of different businesses. A low EV/EBIT compared to a stock’s historical average or industry can indicate undervaluation. EV/EBIT takes into account the reinvestment needs of a business (depreciation, amortization).

Highlights and Quick Summary

Current EV/EBIT of Benitec Biopharma Limited is 0.0 (as of June 30, 2022)
  • EV/EBIT for the quarter ending December 31, 2022 was 0.27 (a Infinity% increase compared to previous quarter)
  • Year-over-year quarterly EV/EBIT increased by Infinity%
  • Annual EV/EBIT for 2022 was 0.0 (a NaN% decrease from previous year)
  • Annual EV/EBIT for 2022 was 0.0 (a -100.0% decrease from previous year)
  • Annual EV/EBIT for 2021 was 0.09 (a Infinity% increase from previous year)
Visit for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EV/EBIT of Benitec Biopharma Limited

Most recent EV/EBITof BNTC including historical data for past 10 years.

Interactive Chart of EV/EBIT of Benitec Biopharma Limited

Benitec Biopharma Limited EV/EBIT for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 0.27 0.0 0.0 0.0
2021 0.0 0.09 0.0 0.09
2020 0.07 0.02 1.12 2.3 1.12
2019 0.0 0.0 0.0
2018 0.0
2017 0.0 0.0
2016 0.0 0.0
2015 0.0
2014 0.0
2013 0.0

Business Profile of Benitec Biopharma Limited

Sector: Healthcare
Industry: Biotechnology